Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 521 days for 2023).
- 202515/07/2026
- 202419/12/2025
- 202318/12/2025
- 202203/07/2023
- 202124/08/2022
- 202014/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Konkaage 54 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-09-17.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $1,422,182.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 29, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,854$1,854 | Fundusz Górnośląski S.A. | |
| Mar 31, 2022 | Aid for research and development projects: industrial research | $65,387$65,387 | Marszałek Województwa Śląskiego | |
| Mar 31, 2022 | Aid for research and development projects: experimental development | $5,132$5,132 | Marszałek Województwa Śląskiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2022-01-01 | Personalized liposomal therapy for acute myeloid leukaemias (OBS/AML) based on small inhibitory RNAs | $777.3K$777,306 | Regional Operational Programme for the Śląskie Voivodeship for 2014-2020 | |
| 2021-03-01 | Scaffold for corneal reconstruction using 3D printing and bioprinting. | $894.5K$894,454 | Regional Operational Programme for the Śląskie Voivodeship for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| Microbe Plussp. z o.o. | $104,197.26 | microbe-plus.com | ||
| Fitomesp. z o.o. | $95,166.11 | fitome.pl | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Biostat Research and Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com |
FAQ
Last updated: 2026-10-07